Spartan Submits COVID-19 Testing System to Health Canada for Investigational Testing Authorization (ITA)
Spartan Bioscience has commenced the regulatory process of its revised COVID-19 point-of-care test and submitted an Investigational Testing Authorization (ITA) application to Health Canada for its review and approval. Upon approval, Spartan will commence the required formal clinical validation studies. We continue to target Health Canada approval for our test system mid-Fall and will provide regular updates moving forward.
We are grateful to the Government of Canada and to provincial governments across the country for supporting this made-in-Canada testing solution. We look forward to doing our part to improve COVID-19 testing capabilities and to help keep Canadians safe and productive during this pandemic.